Integrin ligands and uses thereof
AssigneeArrowhead Pharmaceuticals, Inc.
InventorsZhen Li, Xiaokai Li, Erik W. Bush, Rui Zhu, Dongxu Shu, Jonathan Benson, Patrick Shao, Matthew Fowler-Watters
Life of this patent
Estimating the term…
Abstract
Synthetic αvβ6 integrin ligands of Formula I having serum stability and affinity for integrin αvβ6, which is a receptor expressed in a variety of cell types, are described. The described ligands are useful for delivering cargo molecules, such as RNAi agents or other oligonucleotide-based compounds, to cells that express integrin αvβ6, and thereby facilitating the uptake of the cargo molecules into these cells. Compositions that include αvβ6 integrin ligands and methods of use are also described.
Claims24
An αvβ6 integrin ligand having the structure:
- or a pharmaceutically acceptable salt thereof, wherein X comprises a cargo molecule.
Dependencies are inferred from the claim text.